Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in mul...
Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis
About this item
Full title
Author / Creator
Camacho-Toledano, Celia , Machín-Díaz, Isabel , Calahorra, Leticia , Cabañas-Cotillas, María , Otaegui, David , Castillo-Triviño, Tamara , Villar, Luisa María , Costa-Frossard, Lucienne , Comabella, Manuel , Midaglia, Luciana , García-Domínguez, José Manuel , García-Arocha, Jennifer , Ortega, María Cristina and Clemente, Diego
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Background The increasing number of treatments that are now available to manage patients with multiple sclerosis (MS) highlights the need to develop biomarkers that can be used within the framework of individualized medicine. Fingolimod is a disease-modifying treatment that belongs to the sphingosine-1-phosphate receptor modulators. In addition to...
Alternative Titles
Full title
Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis
Authors, Artists and Contributors
Author / Creator
Machín-Díaz, Isabel
Calahorra, Leticia
Cabañas-Cotillas, María
Otaegui, David
Castillo-Triviño, Tamara
Villar, Luisa María
Costa-Frossard, Lucienne
Comabella, Manuel
Midaglia, Luciana
García-Domínguez, José Manuel
García-Arocha, Jennifer
Ortega, María Cristina
Clemente, Diego
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_0f9c418f15814c33962ee4b700889141
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0f9c418f15814c33962ee4b700889141
Other Identifiers
ISSN
1742-2094
E-ISSN
1742-2094
DOI
10.1186/s12974-022-02635-3
